Lilly posts loss, but beats expectations
Eli Lilly and Co.‘s settlement of Zyprexa litigation sent it to a $466 million loss during its third quarter. But the Indianapolis-based drugmaker exceeded expectations of Wall Street analysts. Lilly spent nearly $1.5 billion to settle a 32-state probe into its marketing and disclosures about Zyprexa, an antipsychotic that is the company’s bestselling drug. It […]